ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Peptide Forums (GHRH, Sermorelin, etc)
General Peptide Use & Information
A human trial of oral BPC-157 was quickly canceled
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="sammmy" data-source="post: 271931" data-attributes="member: 38594"><p>Proving drug safety and effectiveness requires good quality research, not an expensive trial for FDA approval, so that excuse for the really low quality, missing, or contradictory "research" on BPC-157 doesn't fly. Nobody wants it to be FDA approved, but everyone should demand it is well researched, which it is currently not.</p><p></p><p>You clearly have no idea what a case study is. Case studies are extremely cheap and are just the doctor reporting on results of a patient that may have bought the drug themselves and used it. This usually costs $0 to the researcher.</p><p></p><p>Why China and Croatia do not have even case studies is the main question. It could be because the drug is not that effective, or they know it is dangerous, or because they don't want to popularize it only for someone else in US to market it.</p><p></p><p>If you believe BPC-157 is "safe and effective" based on that garbage low quality contradictory research from China and Croatia, basically any drug is good for you.</p></blockquote><p></p>
[QUOTE="sammmy, post: 271931, member: 38594"] Proving drug safety and effectiveness requires good quality research, not an expensive trial for FDA approval, so that excuse for the really low quality, missing, or contradictory "research" on BPC-157 doesn't fly. Nobody wants it to be FDA approved, but everyone should demand it is well researched, which it is currently not. You clearly have no idea what a case study is. Case studies are extremely cheap and are just the doctor reporting on results of a patient that may have bought the drug themselves and used it. This usually costs $0 to the researcher. Why China and Croatia do not have even case studies is the main question. It could be because the drug is not that effective, or they know it is dangerous, or because they don't want to popularize it only for someone else in US to market it. If you believe BPC-157 is "safe and effective" based on that garbage low quality contradictory research from China and Croatia, basically any drug is good for you. [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Peptide Forums (GHRH, Sermorelin, etc)
General Peptide Use & Information
A human trial of oral BPC-157 was quickly canceled
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top